Skip to main content

Metacrine, Inc.

MTCRDelisted Mar 3, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001634379

Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Metacrine, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of MTCR: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders3531−4
Shares11.1M3.30M−7.75M (−70.1%)
Value$37.9M$2.23M−$35.7M (−94.1%)

New holders (7)

Institutions that held Metacrine, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to MTCR in Q4 2021
InstitutionSharesValue% of portfolio
Pura Vida Investments, LLC197,130$133.0K0.01%
Virtu Financial LLC122,366$82.0K0.01%
Acadian Asset Management LLC84,442$56.0K0.00%
Engineers Gate Manager LP81,497$55.0K0.00%
Jane Street Group, LLC69,003$47.0K0.00%
HRT Financial LP23,589$15.0K0.00%
Simplex Trading, LLC2,462$1.00K0.00%

Sold out (11)

Institutions that held Metacrine, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of MTCR in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
NEA Management Company, LLC3,062,977$10.5M
venBio Partners LLC3,059,123$10.5M
Prosight Management, LP1,145,034$3.93M
Franklin Resources Inc363,600$1.25M
ArrowMark Colorado Holdings LLC281,467$965.0K
Deerfield Management Company, L.P. (Series C)277,469$952.0K
Two Sigma Investments, LP123,659$424.0K
Bridgeway Capital Management, LLC94,600$324.0K
New York Life Investments Alternatives88,656$304.0K
Belvedere Trading LLC29,267$102.0K
Prentice Wealth Management LLC750$3.00K